6
Participants
Start Date
November 17, 2023
Primary Completion Date
February 22, 2024
Study Completion Date
February 22, 2024
Intranasal insulin
"Enrolled Participants for this trial will come for 3 study visits. The doses will be administered in varying order: participants will be randomized to one six possible permutations of the intranasal study doses (0, 500, 1000 U) of intranasal insulin at each visit.~Participants will undergo a fMRI scan before and after receiving intranasal doses. Additionally, participants will have blood samples taken."
University of Michigan, Ann Arbor
Florian Schmitzberger
OTHER